Posters
« Back
Streamlining Biologics Development with the Expi Expression Systems
EP30833
Poster Title: Streamlining Biologics Development with the Expi Expression Systems
Submitted on 15 Oct 2019
Author(s): Chao Yan Liu, Jian Liu, Wanhua Yan, Kyle Williston, Kenneth Thompson, Maya Yovcheva, Sara Barnes, Mark Bundy, Melissa Cross, Katy Irvin, Joaquín Canay, Mary Reynolds, Natasha Lucki, Henry Chiou, Andrew Campbell, Jonathan Zmuda
Affiliations:
Poster Views: 944
View poster »


Poster Information
Abstract: Biologics-based medicines is a rapidly growing field and a promising solution to address many unmet medical needs. To meet market demands, biopharmaceutical developers are actively looking for more efficient and robust production platforms to reduce timelines and overall development costs. Throughput, productivity, and scalability of the expression platform, as well as availability of well-documented production cell lines, are key selection criteria when initiating a biologics campaign. To this end, the Gibco™ Expi Expression Systems are complete platforms that can speed up biologics development by enabling rapid, high-yield, and scalable protein or virus production from mammalian (ExpiCHO™ and Expi293™) and insect (ExpiSf™) cells. By providing flexible and high productivity solutions from three different cell hosts using optimized components, the Expi systems support every stage of your biologics development. This unified, end-to-end approach, reduces key product quality risks during development as one can use the same cell line from research to large-scale production while streamlining process development by utilizing integrated reagents for unmatched performance.Summary: Biologics-based medicines is a rapidly growing field and a promising solution to address many unmet medical needs. Biopharmaceutical developers are actively looking for more efficient and robust production platforms to reduce timelines and overall development costs. Gibco™ Expi™ Expression Systems are complete platforms that can speed up biologics development by enabling rapid, high-yield, and scalable protein or virus production from mammalian and insect cells. Report abuse »
Creative Commons

Related Posters


Real-time search of Ubiquitin diGLY modified peptides and PaSER acquisition control on the timsTOF PRO
Christopher Adams1; Robin Park1; Nagarjuna Nagaraj4; Sven Brehmer4; Matt Willetts3; Elizabeth Gordon3; Barry M. Zee2; Hayley Peckham2; Kimberly Lee2; Tharan Srikumar3

Proteomic profiling of IDH mutant gliomas enables prediction of chromosomal copy number variations
Marius Felix 1 2 Dennis Friedel 1 2 Ashok Kumar Jayavelu 4 Uwe Warnken 3 Damian Stichel 1 2 Christel Herold Mende 5 Laura Heikaus 6 Andreas von Deimling 1 2 and David E Reuss 1 2

OpenTIMS TimsPy TimsR: Open Access to timsTOF Pro Raw Data
Mateusz K. Łącki1, Michał P.Startek2, Sven Brehmer3, Christina Bell3, Ute Distler1, Stefan Tenzer1

Novel bifunctional material coupled to PASEF enables sensitive extracellular vesicles phosphoproteomic analysis of urine
Jie Sun1,2, W.Andy Tao3, Xiaoxian Du4 and Xianming Liu4

Implementation of Holistic Glycopeptide PASEF-DDA Data In Diagnostics
Hans JCT Wessels1, Purva Kulkarni1, Fokje Zijlstra1, Merel Post1, Melissa Bärenfänger1, Pierre-Olivier Schmit2, Alain J van Gool1, Dirk J Lefeber1